HHCSY - Healthscope Limited

Other OTC - Other OTC Delayed Price. Currency in USD
8.62
0.00 (0.00%)
At close: 2:58PM EST
Stock chart is not supported by your current browser
Previous Close8.62
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range8.62 - 8.62
52 Week Range8.62 - 8.62
Volume0
Avg. VolumeN/A
Market Cap14.996B
Beta (3Y Monthly)0.21
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.25 (2.89%)
Ex-Dividend Date2019-03-01
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 months ago

    Australia's Healthscope cuts guidance, to vote on Brookfield bid

    Australia's Healthscope Ltd on Tuesday cut its fiscal 2019 hospital operating earnings guidance and set May 22 as the date for shareholders to vote on the takeover bid from Canadian investment firm Brookfield. The hospital operator said its guidance cut was prompted by weaker private hospital market conditions, as well as the prioritisation of public over private patient care in the ramp up of its Northern Beaches Hospital in New South Wales. The company said it was now targeting hospital operating core earnings in a range of A$362 to A$376 million ($258.7 -$268.7 million), or a growth of 5 to 9 percent, from its initial target of at least 10 percent growth on 2018.

  • Reuters2 months ago

    Aussie takeover target Healthscope cuts 2019 guidance

    Australia's Healthscope Ltd on Tuesday cut its fiscal 2019 hospital operating earnings guidance, citing weaker market conditions and a focus on public patient services. The company said it was now targeting hospital operating core earnings in a range of A$362 to A$376 million ($258.7 -$268.7 million), or a growth of 5 to 9 percent, from its initial target of at least 10 percent growth from 2018. Healthscope also said its shareholders would meet on May 22 to vote on a takeover bid from Canadian investment firm Brookfield, which the board has recommended.

  • Reuters3 months ago

    Australia's foreign investment regulator approves Brookfield's takeover of Healthscope

    Australia's Healthscope Ltd said on Tuesday the Foreign Investment Review Board had approved Canadian investment firm Brookfield's takeover offer for the hospital operator along with associated property transactions. After months of negotiations and counter bids from a rival consortium, Healthscope said last month it had entered a scheme of arrangement with Brookfield for a A$4.35 billion ($3.2 billion) takeover.

  • Is Healthscope Limited’s (ASX:HSO) 3.2% ROE Worse Than Average?
    Simply Wall St.5 months ago

    Is Healthscope Limited’s (ASX:HSO) 3.2% ROE Worse Than Average?

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...